Sreekanth Rajan Selected Research

Adenylyl Imidodiphosphate

1/2019

Crystal structure of human vaccinia-related kinase 1 in complex with AMP-PNP, a non-hydrolyzable ATP analog.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sreekanth Rajan Research Topics

Disease

3	Parkinson Disease (Parkinson's Disease) 12/2022 - 07/2015
2	Malaria 07/2014 - 01/2013
1	Asthma (Bronchial Asthma) 01/2021
1	Infections 01/2021
1	Virus Diseases (Viral Diseases) 01/2021
1	Neoplasms (Cancer) 01/2019
1	Vaccinia 01/2019
1	Dyskinesias (Dyskinesia) 07/2015
1	Movement Disorders (Movement Disorder) 07/2015
1	Dengue (Dengue Fever) 07/2012
1	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2011
1	Friedreich Ataxia (Friedreich's Ataxia) 12/2011

Drug/Important Bio-Agent (IBA)

3	Pharmaceutical PreparationsIBA 01/2021 - 07/2012
2	Antiviral Agents (Antivirals)IBA 01/2021 - 07/2012
1	prostaglandin A2 (PGA2)IBA 12/2022
1	montelukast (Singulair)FDA Link 01/2021
1	Glycoproteins (Glycoprotein)IBA 01/2021
1	Melanocyte-Stimulating Hormones (MSH)IBA 01/2021
1	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 01/2021
1	prostaglandin A1 (PGA1)IBA 01/2020
1	Neuroprotective AgentsIBA 01/2020
1	Alprostadil (Muse)FDA LinkGeneric 01/2020
1	Adenosine Triphosphate (ATP)IBA 01/2019
1	Phosphotransferases (Kinase)IBA 01/2019
1	Serine (L-Serine)FDA Link 01/2019
1	Threonine (L-Threonine)FDA Link 01/2019
1	Adenylyl ImidodiphosphateIBA 01/2019
1	Oxidopamine (6 Hydroxydopamine)IBA 07/2015
1	Dopamine (Intropin)FDA LinkGeneric 07/2015
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 07/2015
1	Proteins (Proteins, Gene)FDA Link 07/2014
1	Therapeutic UsesIBA 01/2013
1	Tacrolimus Binding Proteins (FKBP)IBA 01/2013
1	VaccinesIBA 07/2012
1	FrataxinIBA 12/2011